期刊文献+

我国短效口服避孕药安全性系统评估 被引量:3

Systematic Review of the Safety of Daily Pills in China
暂未订购
导出
摘要 目的:评估0、1、2号片、复方左炔诺孕酮单相片和复方左炔诺孕酮三相避孕片的安全性。方法:见“我国常用口服避孕药和宫内节育器系统评估的方法概述”(中国计划生育学杂志,2005年1期17页)。结果:共检索到83篇相关文献,入选20篇。与服药前相比,国产1、2号片和复方左炔诺孕酮单相片对妇女脂代谢的某些指标有影响。与IUD相比,1号片可升高妇女的舒张压。上述脂代谢和血压的改变均无临床意义。0、1号片可能增加心血管意外的风险,但这些影响都较小。结论:国产1、2号片和复方左炔诺孕酮单相片对使用者的脂代谢和血压改变有影响,0、1号片可能增加脑血管意外风险,考虑到心血管意外在年轻健康妇女(≤35岁)中发病率很低,且被评估的短效口服药的雌激素剂量≤35μg/片,故认为被评估的短效口服避孕药对年轻健康使用者心血管疾病的绝对风险很小。 Objective: Review the safety of Pill No 0, No 1, No 2, mono-phasic levonorgestrel and tri-phasic levonorgestrel. Method: Refer to 'Methodology of systematic review of commonly-used oral contraceptives and IUDs in China' (Fang Kejuan, et al. Chinese Journal of Family Planning. 2005, 1) Results: A total of 83 relevant papers were identified, and 20 were included. Compared with per-using cycles, Pill No.1, No.2 and mono-phasic levonorgestrel had negative impact on some plasma lipids components. Compared with IUD, Pill No.1 increased women's diastolic blood pressure. The changes of plasma lipids and blood pressure did not reach clinical significance. Pill No 0 and No 1 might increase risk of cardiovascular diseases. However, all of these risks were low, particularly among the healthy young women. Conclusion: Pill No.1, No.2 and monophasic levonorgestrel have some negative impact on Chinese women's serum lipids and blood pressure. Pill No.0 and No.1 might increase risk of cardiovascular diseases. In view of healthy young women with a low background risk of cardiovascular disease and the evaluated daily pills with low dose(≤35μg/pill) of ethinylestradiol, the risk of cardiovascular disease is very low in these daily pills among healthy young users.
出处 《中国计划生育学杂志》 北大核心 2005年第5期278-283,共6页 Chinese Journal of Family Planning
关键词 中国 短效口服避孕药 安全性 系统评估 Daily Pills Systematic review Safety
  • 相关文献

参考文献36

  • 1[1]Rock J, Garcia C, Pincus G. Synthetic progestins in the normal human menstrual cycle. Recent progress hormone research, 1957,13:323.
  • 2[2]Stadel BV. Oral contraceptives and cardiovascular disease. N Engl J Med,1981,305(11): 612~618.
  • 3[3]Stadel BV. Oral contraceptives and cardiovascular disease. N Engl J Med,1981, 305(12): 672~677.
  • 4[4]WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case - control study. Lancet, 1995,346 (8990): 1575 ~ 1582.
  • 5[5]WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet, 1995,346 (8990): 1582 ~ 1588.
  • 6[6]WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case - control study.Lancet, 1996, 348 (9026): 498 ~ 505.
  • 7[7]WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Haemorrhagic stroke, overall stroke risk, and combined oral contraceptives: results of an international, multicentre,case - control study. Lancet, 1996,348 (9026): 505 ~ 510.
  • 8[8]WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case - control study. Lancet, 1997,349 (9060): 1202 ~ 1209.
  • 9[9]Oral contraceptives and neoplasia: report of a WHO scientific group.WHO technical report series: 817. Geneva. 1992.
  • 10[10]Cardiovascular Disease and Steroid Hormone Contraception: report of a WHO scientific group. WHO technical report series: 877. Geneva.1997.

二级参考文献25

  • 1李瑛,顾晓萍,潘丽,吴玉璘,芮朝星,张云.低剂量国产1号避孕片对脂蛋白、载脂蛋白AI、B和过氧化脂质水平的远期影响[J].生殖与避孕,1993,13(5):331-335. 被引量:2
  • 2李瑛,顾晓萍,杨明明,申素琪,丁婉华.口服避孕药与妇女高血脂和高血压的关系[J].中华流行病学杂志,1995,16(5):285-288. 被引量:8
  • 3齐刚,张莉.绞股蓝研究新进展[J].中草药,1995,26(7):377-380. 被引量:28
  • 4刘辉 雄英 于正荣 等.再发性避孕激素性脑梗塞1例[J].中风与神经疾病杂志,1995,12(2):81-81.
  • 5郭秀文 迟虹 邓宝清 等.口服避孕药致脑梗塞、心肌梗塞死亡1例报告[J].中风与神经疾病杂志,1998,15(3):176-176.
  • 6Hannaford PC, Croft PB, Kay CB. Oral contraception and stroke, evidence from the Boal Collese of General Practitioners'oral contraception study [ see comments ]. Stroke, 1994,25 (5) :935 - 938.
  • 7Philip C Hannaford, Peter R Croft, Croft R. Kay. Oral contraception and stroke - Evidence from the Royal College of General Practitioners oral contraception study. Stroke,1994,25(5) :935 -942.
  • 8Beral V,Hermon C,Kay C,et al.Mortalit associated oral contraceptive tive use:25 year follow of cohort of 46000 women from Royal College of General Practitioners'oral contraception study. British Medical January,1999,318(7176) :96 - 100.
  • 9World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venture thromboembolic disease and combined oral contraceptives: results of international multicentre case - control study. Lancet, 1995,346:1575 - 1582.
  • 10World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. lschaemic stroke and combined oral contraceptives:results of and international,muhicentre,casecontrol study. Lancet, 1996,348:498 - 505.

共引文献45

同被引文献32

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部